Date: 09/09/2025
Time: 12:00 - 13:00 GMT / 13:00 - 14:00 CET
Duration: 1 hour
Whether you're a seasoned regulatory professional or simply curious about the workings of the Dutch regulatory landscape, this webinar promises valuable perspectives and practical knowledge.
Suitable for – TOPRA members and non-members and other healthcare regulatory professionals interested in the Dutch Medicine Evaluation Board.
Benefits for participants
- Learn about the MEB organisation
- Get an insight in the core activities of the MEB
- Opportunity to ask questions
Host

Paula van Hennik, Vice President, Clinical, Regulatory Sciences - Development.
Paula has a PhD in Haematology and has been active in the field of (clinical) regulatory affairs for 14 years with experience as a regulator (11 years at the Medicines Evaluation Board) and has been a consultant for the last two years working for ProPharma as Vice President.
Presenter(s)

Jens van Wijngaarden, Subject Matter Expert,Regulatory Sciences - Development/Propharma
Jens currently works as a subject matter expert strategy at the Regulatory Sciences department at Propharma. In addition, he is director for the European Regulatory Affairs (ERA) course at the SiR Pharma Institute.
Jens holds a PhD in Biomedical Sciences. Following the successful completion of his PhD, he joined the Medicines Evaluation Board (MEB)/College ter Beoordeling van Geneesmiddelen (CBG) – the Dutch medicines registration authority in 2007. Over the course of 15 years, he served as the Board’s main advisor to both the staff and the Scientific Advice Department. He was the Netherlands member of EMA’s Innovation Network as well as the Netherlands ATMP Committee.
The main webinar presentation will run for 45 minutes and will then be followed by a Q&A session.
Pricing
TOPRA Member: Free
Non-member: £45